Algatech announces new appointments

BIOTECHNOLOGY company Algatechnologies welcomes new CEO Ronnie Meninger, who has over 30 years of experience in the fine chemical, special ingredients and pharmaceutical industries. She was managing director of Chemada Fine chemicals, Israel (part of the ICL Group) and is a board member of several public companies in Israel. She holds an MBA and B.Sc in Life Sciences from the Hebrew University of Jerusalem.

Ms Meninger takes over from Hagai Stadler who was interim CEO for the past two years. Mr Stadler, who is from Grovepoint (Algatech's major shareholder) will become a director on the Board of Directors and will be in charge of M&A activities for Algatech.

Algatech CEO Ronnie Meninger

“I’m excited to join Algatech and be part of its excellent team,” says Ms Meninger. “Our strategy for the next years includes major investments in developing unique active ingredients, incorporating innovative technologies to our cultivating process and growing through synergistic acquisitions. In addition, we will offer new delivery forms and increase our focus on compiling more comprehensive scientific data for the AstaPure® brand in order to maintain our distinctive quality, and offer advanced natural astaxanthin solutions to our customers. We also will recruit new key positions and invest further in human resources.”

“I’m very pleased to welcome Ronnie Meninger as the CEO of Algatech,” said Ed Hofland, Algatech’s chairman. “I’m convinced that under Ronnie’s leadership Algatech will continue to grow and show strong performance based on its solid foundations and devoted team. Ronnie’s global experience, coupled with our unquenchable team passion, will enable us to face the dynamic market challenges and continue building Algatech’s global presence.

New chief scientist

The company also announced the appointment of Sammy Boussiba PhD as Chief Scientist to Algatech' Board of Directors. He was nominated by Ms Meninger for the position.

Dr Boussiba is from The Blaustein Institute for Desert Research, Ben Gurion University of the Negev as Chief Scientist to the Board of Directors. He is amongst the world’s leading scientists in microalgae biotechnology and the inventor of the technology used by Algatech for the AstaPure natural astaxanthin production.

Dr Sammy Boussiba joins Algatech's Board of Directors as chief scientist

“Boussiba's nomination is important for our future success,” said Ms Meninger. “Science is one of our company foundations and we aim to increase investment not only in innovation but also in new technologies, sustainable production and improved business models.”